 Validation intermediate end points cancer research Investigations intermediate end points cancer surrogates expensive studies malignancy end point strategy biomarker valid intermediate end point exposure incidence cancer Candidate intermediate end points case series ecologic studies animal experiments Prospective cohort case-control studies intermediate end point-cancer association appropriate measure association attributable proportion intermediate end point valid cancer surrogate attributable proportion close attributable proportion case valid surrogacy intermediate end point exposure-cancer relation turn imply exposure effect intermediate end point relative advantages intervention observational studies validation intermediate end points validation strategy end points adverse reproductive outcomes chronic diseases cancer